Viewing Study NCT04042051


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2026-01-03 @ 10:33 PM
Study NCT ID: NCT04042051
Status: TERMINATED
Last Update Posted: 2025-07-22
First Post: 2019-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
Sponsor: Cancer Trials Ireland
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module